<DOC>
	<DOCNO>NCT01311804</DOCNO>
	<brief_summary>Primary Research Objective : The primary objective study determine efficacy periarticular parecoxib sodium multimodal cocktail versus intravenous parecoxib injection pain management total knee arthroplasty Secondary Research Objective : - To determine perioperative use parecoxib sodium associate improved clinical outcome - To evaluate safety , term adverse event ; serious adverse event tolerability parecoxib sodium periarticular injection multimodal cocktail</brief_summary>
	<brief_title>An Efficacy Safety Study Periarticular Parecoxib Sodium Pain Management Total Knee Arthroplasty</brief_title>
	<detailed_description>This multi-center , open label , parallel randomize trial design evaluate efficacy safety periarticular parecoxib sodium compare intravenous parecoxib sodium . 125 patient primary knee osteoarthritis 4 participate site meet inclusion/exclusion criterion enrol trial . After initial screening , patient attend clinic baseline examination . Subjects randomly allocate periarticular parecoxib sodium intravenous sodium ratio 1:1. patient observe post-operative 6 , 12 , 24 hour , subsequently daily 4 day finally 2 week follow-up</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Patients primary knee osteoarthritis treatment plan unilateral total knee arthroplasty spinal/general anesthesia Subjects age 50 less 85 year Patients body weight least 50 kg 50 % ideal body weight Written inform consent obtain patient guardian Female patient attempt conceive/pregnant Known allergy hypersensitivity cocktail regime COX2 inhibitor History bleed disorder coagulation defect Patients abnormal liver profile Patients history stroke major neurological defect Patients neuropathic pain/sensory disorder Patients peptic ulceration anticoagulant use within 1 month History previous major knee surgery/trauma Patients renal insufficiency History revision total knee arthroplasty Patients knee deformity &gt; 20 degree Patients plan bilateral knee arthroplasty setting Patients significant bone loss require augmentation Patients history use NSAIDs 24 hour surgery</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>